Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations(41 sites)
Australia
Royal Prince Alfred Hospital, Camperdown, New South Wales St Vincent's Hospital Sydney, Darlinghurst, New South Wales St George Hospital, Kogarah, New South Wales Liverpool Hospital, Liverpool, New South Wales John Hunter Hospital, New Lambton Heights, New South Wales Royal North Shore Hospital, Saint Leonards, New South Wales Westmead Hospital, Westmead, New South Wales Royal Darwin Hospital, Tiwi, Northern Territory Cairns Hospital, Cairns, Queensland Royal Brisbane and Women's Hospital, Herston, Queensland Gold Coast University Hospital, Southport, Queensland Princess Alexandra Hospital, Woolloongabba, Queensland Royal Adelaide Hospital, Adelaide, South Australia Flinders Medical Centre, Adelaide, South Australia The Alfred Hospital, Melbourne, Victoria Royal Melbourne Hospital, Melbourne, Victoria Royal Perth Hospital, Perth, Western Australia Belgium
Cliniques Universitaires Saint-Luc, Brussels HUB Hopital Erasme, Brussels CHU-Charleroi Chimay, Charleroi Ziekenhuis Oost-Limburg, Genk Ghent University Hospital, Ghent CHR de la Citadelle de LIEGE, Liège Finland
Helsinki University Hospital (HUS), Helsinki Kuopio University Hospital, Kuopio Turku University Hospital, Turku Germany
University Hospital Münster, Münster Ireland
Beaumont Hospital, Beaumont Cork University Hospital, Cork St Vincent's University Hospital, Dublin New Zealand
Auckland City Hospital, Grafton, Auckland Christchurch Hospital, Christchurch, Christchurch Middlemore Hospital, Auckland, Otahuhu Waikato Hospital, Hamilton, Waikato Region Wellington Hospital, Newtown, Wellington Region Saudi Arabia
King Abdulaziz Medical City, Riyadh Slovenia
University Medical Centre Ljubljana, Ljubljana University Medical Centre Maribor, Maribor Switzerland
University Hospital Bern, Bern Lucerne Cantonal Hospital, Lucerne St. Gallen Cantonal Hospital, Sankt Gallen